Bristol-Myers Squibb Canada Co. v. Mylan Pharmaceuticals ULC re: SUSTIVA®

Represented Bristol-Myers Squibb in a successful proceeding brought under the Patented Medicines (Notice of Compliance) Regulations in which the validity of key patents concerning the drug SUSTIVA® were maintained.